Published in Br J Sports Med on June 05, 2007
Association of the ACTN3 R577X polymorphism with power athlete status in Russians. Eur J Appl Physiol (2008) 1.36
Genes and elite athletes: a roadmap for future research. J Physiol (2011) 1.10
ACTN3 genotype, athletic status, and life course physical capability: meta-analysis of the published literature and findings from nine studies. Hum Mutat (2011) 1.10
Genomics and genetics in the biology of adaptation to exercise. Compr Physiol (2011) 1.02
Association of the ACTN3 genotype and physical functioning with age in older adults. J Gerontol A Biol Sci Med Sci (2008) 0.92
Evidence based selection of commonly used RT-qPCR reference genes for the analysis of mouse skeletal muscle. PLoS One (2014) 0.90
The genetics of sports injuries and athletic performance. Muscles Ligaments Tendons J (2013) 0.89
The ACTN3 genotype in soccer players in response to acute eccentric training. Eur J Appl Physiol (2011) 0.89
Association of the ACTN3 R577X Polymorphism in Polish Power-Orientated Athletes. J Hum Kinet (2011) 0.86
The ACTN3 R577X variant in sprint and strength performance. J Exerc Nutrition Biochem (2014) 0.79
Preliminary Findings of α -Actinin-3 Gene Distribution in Elite Turkish Wind Surfers. Balkan J Med Genet (2013) 0.78
Vitamin D receptor gene polymorphisms and musculoskeletal injuries in professional football players. Exp Ther Med (2015) 0.78
Effective utilization of genetic information for athletes and coaches: focus on ACTN3 R577X polymorphism. J Exerc Nutrition Biochem (2015) 0.77
ACTN3 R577X polymorphism is not associated with team sport athletic status in Italians. Sports Med Open (2015) 0.76
Distribution of Angiotensin-1 Converting Enzyme Insertion/Deletion and α-Actinin-3 Codon 577 Polymorphisms in Turkish Male Soccer Players. Genet Epigenet (2015) 0.75
Translational research and sport sciences. Br J Sports Med (2010) 0.75
The two-hour marathon: who and when? J Appl Physiol (1985) (2010) 25.46
Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science (1992) 6.72
Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells. Curr Biol (1998) 5.94
Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction. J Clin Microbiol (1989) 4.46
Phosphatidylinositol 4,5-bisphosphate functions as a second messenger that regulates cytoskeleton-plasma membrane adhesion. Cell (2000) 4.45
Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell (1998) 3.90
Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative. Cancer Res (1996) 3.77
Physical activity in patients with COPD. Eur Respir J (2008) 3.75
Localized biphasic changes in phosphatidylinositol-4,5-bisphosphate at sites of phagocytosis. J Cell Biol (2000) 3.63
Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun (1992) 3.47
Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science (1999) 3.42
Spatial sensing in fibroblasts mediated by 3' phosphoinositides. J Cell Biol (2000) 3.21
Spatial dynamics of GFP-tagged proteins investigated by local fluorescence enhancement. Nat Biotechnol (1996) 3.19
Efficient chromosome capture requires a bias in the 'search-and-capture' process during mitotic-spindle assembly. Curr Biol (2005) 3.08
Dual role of calmodulin in autophosphorylation of multifunctional CaM kinase may underlie decoding of calcium signals. Neuron (1994) 3.00
Compartmentalized IgE receptor-mediated signal transduction in living cells. J Cell Biol (1997) 2.91
Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition. Neuron (2001) 2.71
Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. J Cell Biol (1998) 2.65
Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli. J Clin Microbiol (1989) 2.62
Tyrosine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol (1998) 2.28
Restricted accumulation of phosphatidylinositol 3-kinase products in a plasmalemmal subdomain during Fc gamma receptor-mediated phagocytosis. J Cell Biol (2001) 2.28
Translocation and reversible localization of signaling proteins: a dynamic future for signal transduction. Cell (2000) 2.27
Nucleocytoplasmic translocation of Stat1 is regulated by a leucine-rich export signal in the coiled-coil domain. Proc Natl Acad Sci U S A (2000) 2.20
Subcellular targeting by membrane lipids. Curr Opin Cell Biol (2001) 2.18
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut (2011) 2.14
Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology (2004) 2.14
CaMKIIbeta functions as an F-actin targeting module that localizes CaMKIIalpha/beta heterooligomers to dendritic spines. Neuron (1998) 2.13
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study. Br J Cancer (2009) 2.13
Calcium-induced restructuring of nuclear envelope and endoplasmic reticulum calcium stores. Cell (1997) 1.96
Internal trafficking and surface mobility of a functionally intact beta2-adrenergic receptor-green fluorescent protein conjugate. Mol Pharmacol (1997) 1.96
Retracted Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class. Proc Natl Acad Sci U S A (1995) 1.93
Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry (1998) 1.86
A versatile microporation technique for the transfection of cultured CNS neurons. J Neurosci Methods (1999) 1.80
Self-administered topical 5% imiquimod for the treatment of common warts and molluscum contagiosum. Br J Dermatol (2000) 1.76
Molecular memory by reversible translocation of calcium/calmodulin-dependent protein kinase II. Nat Neurosci (2000) 1.74
Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2. Eur J Biochem (1995) 1.69
Maternal and fetal sequelae of anticoagulation during pregnancy in patients with mechanical heart valve prostheses. Am J Cardiol (1989) 1.68
Elementary calcium-release units induced by inositol trisphosphate. Science (1997) 1.67
PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anticancer Drug Des (2000) 1.63
Does exercise training during pregnancy affect gestational age? A randomised controlled trial. Br J Sports Med (2008) 1.60
Electroporation-induced formation of individual calcium entry sites in the cell body and processes of adherent cells. Biophys J (1997) 1.58
Combined action of mouse alpha and beta interferons in influenza virus-infected macrophages carrying the resistance gene Mx. J Virol (1984) 1.52
Estrogen-induced activation of mitogen-activated protein kinase requires mobilization of intracellular calcium. Proc Natl Acad Sci U S A (1999) 1.46
[Successful lysis of iliofemoral and inferior vena cava thrombi in heparin-induced type-II thrombocytopenia]. Dtsch Med Wochenschr (1997) 1.42
Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. J Natl Cancer Inst (1974) 1.42
Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun (1998) 1.38
Protein kinase C and mammary cell differentiation: involvement of protein kinase C alpha in the induction of beta-casein expression. Cell Growth Differ (1994) 1.37
Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol (2001) 1.35
Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer (2002) 1.32
Reversible desensitization of inositol trisphosphate-induced calcium release provides a mechanism for repetitive calcium spikes. J Biol Chem (1996) 1.29
Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison. J Clin Pathol (1999) 1.26
Physical training improves skeletal muscle metabolism in patients with chronic heart failure. J Am Coll Cardiol (1993) 1.24
Actigraph GT3X: validation and determination of physical activity intensity cut points. Int J Sports Med (2013) 1.24
Coordinated oscillations in cortical actin and Ca2+ correlate with cycles of vesicle secretion. Nat Cell Biol (2012) 1.23
Control of astrocyte Ca(2+) oscillations and waves by oscillating translocation and activation of protein kinase C. Curr Biol (2001) 1.20
Source of nuclear calcium signals. Proc Natl Acad Sci U S A (1994) 1.17
Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett (1994) 1.16
Localized calcium spikes and propagating calcium waves. Cell Calcium (1993) 1.16
Development and evaluation of an implementation strategy for the German guideline on community-acquired pneumonia. Qual Saf Health Care (2010) 1.16
Lymphogranuloma venereum emerging in men who have sex with men in Germany. Euro Surveill (2006) 1.15
Prenylation-dependent association of Ki-Ras with microtubules. Evidence for a role in subcellular trafficking. J Biol Chem (1997) 1.14
Glomerular permeability barrier in the rat. Functional assessment by in vitro methods. J Clin Invest (1993) 1.14
Total deposition of therapeutic particles during spontaneous and controlled inhalations. J Pharm Sci (2000) 1.13
Clinical and genetic aspects of Shiga-like toxin production in traditional enteropathogenic Escherichia coli. Zentralbl Bakteriol (1991) 1.13
Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand (2008) 1.13
Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(phenylamino)pyrazolo[3,4-d]pyrimidines. J Med Chem (1997) 1.13
Association of the beta isoform of protein kinase C with vimentin filaments. Cell Motil Cytoskeleton (1992) 1.12
Fibrolamellar hepatocellular carcinoma: prolonged survival with multimodality therapy. Eur J Surg Oncol (2009) 1.12
Decoding calcium signals by multifunctional CaM kinase. Cell Calcium (1992) 1.12
Exercise in adult and pediatric hematological cancer survivors: an intervention review. Leukemia (2010) 1.12
In vivo therapy of malignant melanoma by means of antagonists of alphav integrins. Int J Cancer (2000) 1.11
Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy. Eur J Surg Oncol (2008) 1.11
Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem Pharmacol (1997) 1.09
In vivo and in vitro characterization of the sequence requirement for oligomer formation of Ca2+/calmodulin-dependent protein kinase IIalpha. J Neurochem (1998) 1.09
Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J (2009) 1.09
Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res (2002) 1.08
Novel missense and truncating mutations in FUS/TLS in familial ALS. Neurology (2010) 1.08
Impurity absorption spectroscopy in 28Si: the importance of inhomogeneous isotope broadening. Phys Rev Lett (2003) 1.07
Double mutant studies identify electrostatic interactions that are important for docking cytochrome c2 onto the bacterial reaction center. Biochemistry (2002) 1.07
Differential codes for free Ca(2+)-calmodulin signals in nucleus and cytosol. Curr Biol (2000) 1.07
The sweating response of elite professional soccer players to training in the heat. Int J Sports Med (2005) 1.07
Does prolonged cycling of moderate intensity affect immune cell function? Br J Sports Med (2005) 1.06
Expression and partial characterization of rat protein kinase C-delta and protein kinase C-zeta in insect cells using recombinant baculovirus. J Cell Biochem (1992) 1.06
Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes (1990) 1.06
Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. J Biol Chem (1990) 1.05
Visualization of dynamic trafficking of a protein kinase C betaII/green fluorescent protein conjugate reveals differences in G protein-coupled receptor activation and desensitization. J Biol Chem (1998) 1.05
Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J Virol (1998) 1.04
Selective GRB2 SH2 inhibitors as anti-Ras therapy. Int J Cancer (1999) 1.04
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Ann Oncol (2013) 1.04
Verocytotoxin-producing Escherichia coli O2:H5 isolated from patients with ulcerative colitis. Lancet (1989) 1.03
ACTN3 genotype in professional endurance cyclists. Int J Sports Med (2006) 1.03
Use of intracellular Ca2+ stores from rat basophilic leukemia cells to study the molecular mechanism leading to quantal Ca2+ release by inositol 1,4,5-trisphosphate. Biochemistry (1993) 1.03
Functional capacity of children with leukemia. Int J Sports Med (2007) 1.03
Design, synthesis and investigation of mechanisms of action of novel protein kinase C inhibitors: perylenequinonoid pigments. Biochem Pharmacol (1994) 1.03
Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients. Br J Cancer (2008) 1.02
Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours. Br J Cancer (2010) 1.02
Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia (2005) 1.02
Luminal calcium regulates the inositol trisphosphate receptor of rat basophilic leukemia cells at a cytosolic site. Biochemistry (1995) 1.01
Benefits of intrahospital exercise training after pediatric bone marrow transplantation. Int J Sports Med (2007) 1.01